Evidence map›Paper›PMID 29333564›Full record

ArticleAnnals of nuclear medicine2018

Is

Kenichi Nakajima, Koichi Okuda, Shinro Matsuo, Hiroshi Wakabayashi, Seigo Kinuya

Open access · hybridAbstract read
In one paragraph

Article in Annals of nuclear medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. [PCN reports : psychiatry and clinical neurosciences · 2025
    Article
  5. SympatheticAnnals of nuclear medicine · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Machine learning-based risk model usingJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  13. Article
  14. What does diagnostic threshold mean? Deterministic and probabilistic considerations.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  15. CardiacJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kenichi NakajimaDepartment of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. nakajima@med.kanazawa-u.ac.jp.ORCID http://orcid.org/0000-0001-7188-8746
Koichi OkudaDepartment of Physics, Kanazawa Medical University, Uchinada, Kahoku, Japan.
Shinro MatsuoDepartment of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.
Hiroshi WakabayashiDepartment of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.
Seigo KinuyaDepartment of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.
Kanazawa University Hospital · JPKanazawa Medical University · JP

Funding

FUJIFILM RI Pharma N/AJSNM working group N/AJSPS Grants-in-Aid for Scientific Research 15 K09947
6 · The paper itself

Abstract

backgroundHeart-to-mediastinum ratios (HMRs) of

methodsWe analyzed 62 patients (average age 57 ± 19 years, male 45%) derived from a normal database of the Japanese Society of Nuclear Medicine working group. The HMR was calculated from early (15 min) and delayed (3-4 h) anterior planar

resultsBefore standardization of HMR to MEGP collimator conditions, HMR and age did not significantly correlate. However, late HMR significantly correlated with age after standardization: late HMR = - 0.0071 × age + 3.69 (r

conclusionWhile late HMR was slightly decreased in elderly patients, the lower limit of 2.2-2.3 can still be used to determine both early and late HMR.

Indexed as

3-IodobenzylguanidineAgingRadionuclide ImagingRadiopharmaceuticalsAdultAgedAged, 80 and overDatabases as TopicFemaleHeartHumansJapanMaleMediastinumMiddle AgedNuclear Medicine3-IodobenzylguanidineRadiopharmaceuticalsAgingQuantitationScintigraphyStandardizationSympathetic imaging

Identifiers

PMID29333564
PMCPMC5852176
OpenAlexW2783233536

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.